0.8216
Finanzdaten der Biofrontera Inc-Aktie (BFRI)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
19.03%
12.00
|
10.08 | 17.10 | 6.988 | 9.03 |
|
|
13.03%
12.53
|
14.40 | - | 13.27 | - |
| Costs And Expenses |
13.03%
12.53
|
14.40 | 12.54 | 13.27 | 14.11 |
| Operating Income/Loss |
87.87%
-0.524
|
-4.32 | 4.559 | -6.278 | -5.079 |
| Nonoperating Income/Loss |
86.81%
-0.057
|
-0.432 | 1.081 | -0.365 | -0.224 |
| Income/Loss From Continuing Operations Before Tax |
87.77%
-0.581
|
-4.752 | 5.64 | -6.643 | -5.303 |
| Income Tax Expense/Benefit |
0.023
|
- | - | 0.006 | 0.021 |
| Net Income/Loss |
87.29%
-0.604
|
-4.752 | 5.64 | -6.649 | -5.324 |
| Basic Average Shares |
10.62%
12.92
|
11.68 | - | 10.78 | 9.3516 |
| Diluted Average Shares |
10.62%
12.92
|
11.68 | - | 10.78 | 9.3516 |
| Basic Earnings Per Share |
87.80%
-0.05
|
-0.41 | - | -0.62 | -0.57 |
| Diluted Earnings Per Share |
87.80%
-0.05
|
-0.41 | - | -0.62 | -0.57 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):